Merlin Names Bob Smith Chairman and Interim CEO; Founder Matt George Transitions to Founder and Advisor
On November 18, 2026, Matthew George transitioned from Chief Executive Officer, Chairman and director to the role of Founder and Advisor, and the Board appointed director Dr. Robert H. Smith as Chairman and Interim Chief Executive Officer effective the same date. The Board is commencing a search for a permanent CEO and will consider both internal and external candidates. George's Transition Agreement provides a $937,500 separation cash payment, a $625,000 2026 target annual bonus, 18 months of subsidized COBRA c...
Key takeaways
Leadership change: Founder Matthew George transitioned from Chief Executive Officer, Chairman and member of the Board to the role of Founder and Advisor effective November 18, 2026.
Interim leadership: The Board appointed Dr. Robert H. Smith (Bob Smith), a director since March 16, 2026, as Chairman and Interim Chief Executive Officer effective November 18, 2026, with a permanent CEO search underway covering internal and external candidates.
Smith background: He was CEO of Blue Origin from 2017 to 2024, where the press release states annual sales grew from nearly zero to more than $750 million and an order book of approximately $10 billion was built; he previously held leadership roles at Honeywell Aerospace and is currently a director of Parsons Corporation and a Senior Advisor to the Office of the Secretary of Defense under the BOND program.
George separation terms: A $937,500 cash payment (one and one-half times base salary) payable in 18 monthly installments, a $625,000 2026 performance-period target bonus paid in a lump sum, 18 months of subsidized health insurance, and an additional $937,500 plus six months of health subsidy if a Change in Control occurs within three years of the Effective Date.
George advisory arrangement: He serves as an independent consultant with a $6,250 monthly fee (pro-rated), limited to no more than 15 hours per month, through the first anniversary of the Effective Date, with non-compete, non-solicit, non-interference and non-disparagement covenants and a three-year standstill.
Smith compensation: $48,000 per month base salary, a 500,000-share Interim CEO RSU Award vesting on the earlier of the six-month anniversary or the conclusion of service, and a 1,500,000-share Additional RSU Award vesting in twelve monthly installments with no fewer than 1,000,000 shares vesting on a qualifying early end of term; unvested awards vest on a change of control.
Interim term: Dr. Smith's service runs for six months, extendable for successive three-month periods by mutual agreement, and ends on the earlier of a permanent CEO appointment, conclusion of a term without mutual extension, or resignation or termination for any reason.
Key metrics
Primary source
TickerStar generated this brief from an official company, investor-relations, earnings-call, or regulatory source. Review the primary material before making an investment decision.
Open SEC filingFollow MRLN in real time
Get material earnings, filing, IR, and earnings-call alerts by email.